| Literature DB >> 9241615 |
Abstract
It has been well established that a percentage of patients receiving interferon (IFN) produce antibodies that can neutralize its action or bind to the molecule. There are also indications that the development of neutralizing antibodies to IFN may be associated with failure of IFN therapy. This article reviews such observations and addresses some of the continuing questions on this issue.Entities:
Mesh：
Substances：
Year: 1997 PMID： 9241615
Source DB: PubMed Journal: J Interferon Cytokine Res ISSN： 1079-9907 Impact factor: 2.607